Wells Fargo & Company MN lifted its position in Xylem Inc (NYSE:XYL) by 10.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 202,353 shares of the industrial products company’s stock after purchasing an additional 19,393 shares during the period. Wells Fargo & Company MN owned about 0.11% of Xylem worth $12,675,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of XYL. Janus Henderson Group PLC grew its holdings in shares of Xylem by 404.5% in the second quarter. Janus Henderson Group PLC now owns 1,853,943 shares of the industrial products company’s stock worth $102,758,000 after purchasing an additional 1,486,463 shares during the last quarter. Voya Investment Management LLC boosted its holdings in Xylem by 554.0% in the second quarter. Voya Investment Management LLC now owns 1,242,748 shares of the industrial products company’s stock valued at $68,886,000 after acquiring an additional 1,052,719 shares in the last quarter. State Street Corp boosted its holdings in Xylem by 11.5% in the second quarter. State Street Corp now owns 8,360,506 shares of the industrial products company’s stock valued at $460,211,000 after acquiring an additional 861,484 shares in the last quarter. PointState Capital LP bought a new stake in Xylem in the second quarter valued at $34,128,000. Finally, Bank of New York Mellon Corp boosted its holdings in Xylem by 31.6% in the third quarter. Bank of New York Mellon Corp now owns 2,027,810 shares of the industrial products company’s stock valued at $127,002,000 after acquiring an additional 487,360 shares in the last quarter. Hedge funds and other institutional investors own 85.09% of the company’s stock.

Xylem Inc (NYSE XYL) opened at $67.58 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $12,167.90, a price-to-earnings ratio of 39.29, a price-to-earnings-growth ratio of 1.89 and a beta of 1.17. Xylem Inc has a 52-week low of $46.67 and a 52-week high of $69.88.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.64 by $0.01. The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. Xylem had a return on equity of 17.74% and a net margin of 6.85%. The company’s revenue for the quarter was up 33.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 earnings per share. equities research analysts forecast that Xylem Inc will post 2.39 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 6th. Shareholders of record on Thursday, November 2nd were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend was Wednesday, November 1st. Xylem’s dividend payout ratio is currently 41.86%.

Several research firms recently weighed in on XYL. Zacks Investment Research cut shares of Xylem from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Canaccord Genuity reiterated a “hold” rating and issued a $65.00 price target on shares of Xylem in a report on Monday, December 11th. Boenning Scattergood reiterated a “buy” rating on shares of Xylem in a report on Friday, December 15th. Seaport Global Securities reiterated a “buy” rating on shares of Xylem in a report on Wednesday, November 1st. Finally, Oppenheimer lifted their price target on shares of Xylem from $66.00 to $75.00 and gave the company an “outperform” rating in a report on Wednesday, November 1st. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Xylem currently has an average rating of “Buy” and a consensus price target of $65.17.

In other Xylem news, insider Colin R. Sabol sold 38,070 shares of the firm’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $65.81, for a total transaction of $2,505,386.70. Following the completion of the transaction, the insider now owns 61,979 shares of the company’s stock, valued at $4,078,837.99. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven R. Loranger sold 37,700 shares of the firm’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $66.25, for a total value of $2,497,625.00. Following the transaction, the director now directly owns 58,831 shares of the company’s stock, valued at approximately $3,897,553.75. The disclosure for this sale can be found here. Insiders have sold 150,777 shares of company stock valued at $10,097,757 in the last three months. Insiders own 0.75% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://theolympiareport.com/2017/12/25/xylem-inc-xyl-stake-lifted-by-wells-fargo-company-mn.html.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with Analyst Ratings Network's FREE daily email newsletter.